These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3258212)

  • 1. Mechanisms of human CD5 modulation and capping induced by murine monoclonal antibody T101.
    Shawler DL; Johnson DE; McCallister TJ; Bartholomew RM; Dillman RO
    Clin Immunol Immunopathol; 1988 May; 47(2):219-29. PubMed ID: 3258212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of in vitro and in vivo antigenic modulation by the anti-human T-cell monoclonal antibody T101.
    Shawler DL; Miceli MC; Wormsley SB; Royston I; Dillman RO
    Cancer Res; 1984 Dec; 44(12 Pt 1):5921-7. PubMed ID: 6333922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T65 antigen modulation in a phase I monoclonal antibody trial with chronic lymphocytic leukemia patients.
    Schroff RW; Farrell MM; Klein RA; Oldham RK; Foon KA
    J Immunol; 1984 Sep; 133(3):1641-8. PubMed ID: 6379051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic modulation by anti-CD5 immunotoxins.
    Manske JM; Buchsbaum DJ; Azemove SM; Hanna DE; Vallera DA
    J Immunol; 1986 Jun; 136(12):4721-8. PubMed ID: 3086441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous infusion of T101 monoclonal antibody in chronic lymphocytic leukemia and cutaneous T-cell lymphoma.
    Dillman RO; Beauregard J; Shawler DL; Halpern SE; Markman M; Ryan KP; Baird SM; Clutter M
    J Biol Response Mod; 1986 Oct; 5(5):394-410. PubMed ID: 3490543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I study of the pharmacokinetics of a radioimmunoconjugate, 90Y-T101, in patients with CD5-expressing leukemia and lymphoma.
    Foss FM; Raubitscheck A; Mulshine JL; Fleisher TA; Reynolds JC; Paik CH; Neumann RD; Boland C; Perentesis P; Brown MR; Frincke JM; Lollo CP; Larson SM; Carrasquillo JA
    Clin Cancer Res; 1998 Nov; 4(11):2691-700. PubMed ID: 9829731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody T101 in T cell malignancies: a clinical, pharmacokinetic, and immunologic correlation.
    Bertram JH; Gill PS; Levine AM; Boquiren D; Hoffman FM; Meyer P; Mitchell MS
    Blood; 1986 Sep; 68(3):752-61. PubMed ID: 3488778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue distribution and serum kinetics of T101 monoclonal antibody during passive anti-cancer therapy.
    Shawler DL; Beauregard J; Halpern SE; Baird SM; Dillman RO
    Clin Immunol Immunopathol; 1986 Oct; 41(1):43-54. PubMed ID: 3488861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of monoclonal antibody therapy in patients with chronic lymphocytic leukemia.
    Foon KA; Schroff RW; Bunn PA; Mayer D; Abrams PG; Fer M; Ochs J; Bottino GC; Sherwin SA; Carlo DJ
    Blood; 1984 Nov; 64(5):1085-93. PubMed ID: 6333257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing effects of monocytes on modulation of a lymphocyte membrane antigen.
    Schroff RW; Klein RA; Farrell MM; Stevenson HC
    J Immunol; 1984 Oct; 133(4):2270-7. PubMed ID: 6236264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis.
    Camussi G; Brentjens JR; Noble B; Kerjaschki D; Malavasi F; Roholt OA; Farquhar MG; Andres G
    J Immunol; 1985 Oct; 135(4):2409-16. PubMed ID: 3875653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy of chronic lymphocytic leukemia and cutaneous T-cell lymphoma with T101 monoclonal antibody.
    Dillman RO; Shawler DL; Dillman JB; Royston I
    J Clin Oncol; 1984 Aug; 2(8):881-91. PubMed ID: 6379121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the cytotoxic potency of T101 Fab, F(ab')2 and whole IgG immunotoxins.
    Derocq JM; Casellas P; Laurent G; Ravel S; Vidal H; Jansen F
    J Immunol; 1988 Oct; 141(8):2837-43. PubMed ID: 3262669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human IgE, IgG and IgA antibody responses to T101, a murine monoclonal antibody against human lymphocytes: implications for pathogenesis, risk and avoidance of adverse immunologic reactions.
    Dykewicz MS; Cranberg JA; Patterson R; Rosen ST; Shaughnessy MA; Zimmer AM
    Int Arch Allergy Appl Immunol; 1990; 92(2):131-7. PubMed ID: 2242927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine monoclonal antibody therapy in two patients with chronic lymphocytic leukemia.
    Dillman RO; Shawler DL; Sobol RE; Collins HA; Beauregard JC; Wormsley SB; Royston I
    Blood; 1982 May; 59(5):1036-45. PubMed ID: 6896161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human T cell antigens defined by monoclonal antibodies: the 65,000-dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin.
    Royston I; Majda JA; Baird SM; Meserve BL; Griffiths JC
    J Immunol; 1980 Aug; 125(2):725-31. PubMed ID: 6993560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mathematical modeling for antibody therapy in the setting of antigenic modulation.
    Dillman RO; Koziol JA; Shawler DL
    Mol Biother; 1988; 1(1):46-52. PubMed ID: 3267371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).
    Al Saati T; Laurent G; Caveriviere P; Rigal F; Delsol G
    Clin Exp Immunol; 1984 Dec; 58(3):631-8. PubMed ID: 6239721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capping of human T cell specific determinants: kinetics of capping and receptor re-expression and regulation by the cytoskeleton.
    Kammer GM; Smith JA; Mitchell R
    J Immunol; 1983 Jan; 130(1):38-44. PubMed ID: 6600189
    [No Abstract]   [Full Text] [Related]  

  • 20. CD5+B cells: differential capping and modulation of IgM and CD5.
    Jamin C; Lydyard PM; Le Corre R; Youinou PY
    Scand J Immunol; 1996 Jan; 43(1):73-80. PubMed ID: 8560199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.